- Home
- LILAK vs ABCL Comparison
LILAK vs ABCL Comparison
Compare LILAK & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LILAK
- ABCL
- Stock Information
- Founded
- LILAK 2017
- ABCL 2012
- Country
- LILAK Bermuda
- ABCL Canada
- Employees
- LILAK N/A
- ABCL N/A
- Industry
- LILAK Cable & Other Pay Television Services
- ABCL Biotechnology: Pharmaceutical Preparations
- Sector
- LILAK Telecommunications
- ABCL Health Care
- Exchange
- LILAK Nasdaq
- ABCL Nasdaq
- Market Cap
- LILAK 1.1B
- ABCL 1.1B
- IPO Year
- LILAK N/A
- ABCL 2020
- Fundamental
- Price
- LILAK $8.13
- ABCL $4.39
- Analyst Decision
- LILAK Buy
- ABCL Strong Buy
- Analyst Count
- LILAK 2
- ABCL 5
- Target Price
- LILAK $7.90
- ABCL $8.00
- AVG Volume (30 Days)
- LILAK 1.9M
- ABCL 5.5M
- Earning Date
- LILAK 08-07-2025
- ABCL 08-07-2025
- Dividend Yield
- LILAK N/A
- ABCL N/A
- EPS Growth
- LILAK N/A
- ABCL N/A
- EPS
- LILAK N/A
- ABCL N/A
- Revenue
- LILAK $4,409,700,000.00
- ABCL $32,875,999.00
- Revenue This Year
- LILAK $1.89
- ABCL N/A
- Revenue Next Year
- LILAK $3.13
- ABCL $71.11
- P/E Ratio
- LILAK N/A
- ABCL N/A
- Revenue Growth
- LILAK N/A
- ABCL N/A
- 52 Week Low
- LILAK $4.23
- ABCL $1.89
- 52 Week High
- LILAK $10.67
- ABCL $5.82
- Technical
- Relative Strength Index (RSI)
- LILAK 72.72
- ABCL 51.44
- Support Level
- LILAK $7.51
- ABCL $4.01
- Resistance Level
- LILAK $8.23
- ABCL $4.81
- Average True Range (ATR)
- LILAK 0.37
- ABCL 0.36
- MACD
- LILAK 0.00
- ABCL -0.05
- Stochastic Oscillator
- LILAK 70.03
- ABCL 42.59
About LILAK Liberty Latin America Ltd. Class C
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.